Geoffrey M. Parker insider trades
Open-market stock purchases and sales by Geoffrey M. Parker, Director at PERRIGO Co plc, from SEC Form 4 filings since Jun 1, 2010.
Track record: 0% of 10 scored buys are up 5% or more since purchase, averaging -54%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 11, 2026 | PRGO PERRIGO Co plc | Sold (not open market) | $8.3K |
| Sep 11, 2026 | PRGO PERRIGO Co plc | Bought (not open market) | — |
| Jun 12, 2026 | PRGO PERRIGO Co plc | Sold (not open market) | $5.2K |
| Jun 12, 2026 | PRGO PERRIGO Co plc | Bought (not open market) | — |
| Jun 12, 2026 | PRGO PERRIGO Co plc | Bought (not open market) | — |
| May 14, 2026 | PRGO PERRIGO Co plc | Sold (not open market) | $38K |
| May 14, 2026 | PRGO PERRIGO Co plc | Bought (not open market) | — |
| May 13, 2026 | PRGO PERRIGO Co plc | Bought (not open market) | — |
| Mar 13, 2026 | PRGO PERRIGO Co plc | Bought (not open market) | — |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc | Sold | $42.2K |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc | Bought (not open market) | — |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc | Bought (not open market) | — |
| Dec 12, 2025 | PRGO PERRIGO Co plc | Bought (not open market) | — |
| Nov 12, 2025 | PRGO PERRIGO Co plc | Bought | $106K |
| Oct 21, 2025 | ALLO Allogene Therapeutics, Inc | Sold | $46.2K |
Companies traded
- PRGO PERRIGO Co plc: 10 buys, last Sep 11, 2026
- ALLO Allogene Therapeutics, Inc: 1 buy, 3 sales, last Feb 2, 2026
- BTTX Better Therapeutics, Inc: 5 buys, last Dec 18, 2023
- CCXI ChemoCentryx, Inc: 7 buys, 10 sales, last Oct 20, 2022
- TCDA Tricida, Inc: 14 buys, last Feb 28, 2022
- GHDX Genomic Health Inc: other filings, last Nov 8, 2019
- SNSS Sunesis Pharmaceuticals Inc: 7 buys, last May 31, 2017
- ANAC Anacor Pharmaceuticals, Inc: 28 buys, last Mar 23, 2015
- GXDX Genoptix Inc: other filings, last Feb 25, 2011